Marjorie Clifton, executive director of CSIP, is attending the 2013 World Trade Organization (WTO) Public Forum in Geneva from Oct 1-3, 2013. This year’s focus is “Expanding Trade through Innovation in the Digital Economy”. Marjorie is speaking on the panel … Continue reading →

The United States House of Representatives recently passed a bill called the The Safeguarding Pharmaceuticals Act (H.R.1919), intended to set up a national system for tracking drugs through the supply chain to prevent counterfeit medicines from accessing the market (see … Continue reading →

Prescription drugs often follow a long path, through wholesalers and re-packagers, before reaching pharmacies, and ultimately consumers. Counterfeit drugs, however, are typically not produced under safe manufacturing conditions and they are not inspected by regulatory authorities. Therefore, it can be … Continue reading →

The U.S. Commerce Department-run website STOPfakes.gov is an initiative to protect intellectual property rights in the global marketplace that offers resources to educate consumers and businesses about counterfeit products. STOPfakes.gov has included the Center for Safe Online Pharmacies, and its two ex-officio members LegitScript and the Alliance for Safe … Continue reading →

The National Association of Boards of Pharmacy (NABP) recently released the Internet Drug Outlet Identification Program Progress Report, a quarterly report that surveys approximately 10,000 different pharmacy websites. The findings in the latest report emphasize why certain pharmacies are “not … Continue reading →